Meyka Pro banner
Amarin Corporation plc

Amarin Corporation plc Fundamental Analysis (NASDAQ: AMRN)

AMRN●NASDAQ
HealthcareDrug Manufacturers - General
$11.57
$0.18(1.53%)
U.S. Market is Open · 12:48

Amarin Corporation plc Fundamental Analysis (NASDAQ: AMRN)

Amarin Corporation plc (NASDAQ: AMRN) shows weak financial fundamentals with a PE ratio of -11.14, profit margin of -10.87%, and ROE of -4.26%. The company generates $0.2B in annual revenue with weak year-over-year growth of -6.55%.

Key Strengths

Cash Position132.63%
PEG Ratio-0.08
Current Ratio3.50

Areas of Concern

ROE-4.26%
Operating Margin-13.97%
We analyze AMRN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 16.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
16.0/100

We analyze AMRN's fundamental strength across five key dimensions:

Efficiency Score

Weak

AMRN struggles to generate sufficient returns from assets.

ROA > 10%
-3.02%

Valuation Score

Excellent

AMRN trades at attractive valuation levels.

PE < 25
-11.14
PEG Ratio < 2
-0.08

Growth Score

Moderate

AMRN shows steady but slowing expansion.

Revenue Growth > 5%
-6.55%
EPS Growth > 10%
55.00%

Financial Health Score

Excellent

AMRN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
3.50

Profitability Score

Weak

AMRN struggles to sustain strong margins.

ROE > 15%
-426.09%
Net Margin ≥ 15%
-10.87%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is AMRN Expensive or Cheap?

P/E Ratio

AMRN trades at -11.14 times earnings. This suggests potential undervaluation.

-11.14

PEG Ratio

When adjusting for growth, AMRN's PEG of -0.08 indicates potential undervaluation.

-0.08

Price to Book

The market values Amarin Corporation plc at 0.55 times its book value. This may indicate undervaluation.

0.55

EV/EBITDA

Enterprise value stands at -21.79 times EBITDA. This is generally considered low.

-21.79

How Well Does AMRN Make Money?

Net Profit Margin

For every $100 in sales, Amarin Corporation plc keeps $-10.87 as profit after all expenses.

-10.87%

Operating Margin

Core operations generate -13.97 in profit for every $100 in revenue, before interest and taxes.

-13.97%

ROE

Management delivers $-4.26 in profit for every $100 of shareholder equity.

-4.26%

ROA

Amarin Corporation plc generates $-3.02 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.02%

Following the Money - Real Cash Generation

Operating Cash Flow

Amarin Corporation plc generates strong operating cash flow of $70.68M, reflecting robust business health.

$70.68M

Free Cash Flow

Amarin Corporation plc generates strong free cash flow of $70.68M, providing ample flexibility for dividends, buybacks, or growth.

$70.68M

FCF Per Share

Each share generates $3.42 in free cash annually.

$3.42

FCF Yield

AMRN converts 29.48% of its market value into free cash.

29.48%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-11.14

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.55

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.37

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.50

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.04

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.05

vs 25 benchmark

How AMRN Stacks Against Its Sector Peers

MetricAMRN ValueSector AveragePerformance
P/E Ratio-11.1431.66 Better (Cheaper)
ROE-4.26%501.00% Weak
Net Margin-10.87%-3647.00% (disorted) Weak
Debt/Equity0.02-0.30 (disorted) Distorted
Current Ratio3.505.78 Strong Liquidity
ROA-3.02%-262.00% (disorted) Weak

AMRN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Amarin Corporation plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-69.82%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-86.99%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

126.90%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ